+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake



A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake



Bioorganic and Medicinal Chemistry 20(21): 6344-6355



A group of spirocyclic tropanyl-Δ(2)-isoxazolines was synthesized exploiting the 1,3-dipolar cycloaddition of nitrile oxides to olefins. Their interaction with the dopamine and serotonin transporters (DAT and SERT, respectively) was evaluated through binding experiments. The majority of the compounds had no inhibitory effects (IC(50) >> 10 μM), while some had an IC(50) value in the range 5-10 μM (8a-c, 10b and 11c on DAT, 12b on SERT). Unexpectedly, one of the tertiary amines under investigation, that is 3'-methoxy-8-methyl-spiro{8-azabicyclo[3.2.1]octane-3,5'(4'H)-isoxazole 7a, was able to enhance at a concentration of 10 μM both [(3)H]citalopram and [(3)H]paroxetine binding to SERT in rat brain homogenate (up to 25%, due to an increase of B(max)) and [(3)H]serotonin uptake (up to 30%) in cortical synaptosomes. This peculiar pharmacological profile of 7a suggests it binds to an allosteric site on SERT, and positions derivative 7a as a very useful tool to investigate SERT machinery.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051200832

Download citation: RISBibTeXText

PMID: 23022052

DOI: 10.1016/j.bmc.2012.09.004


Related references

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. American Journal of Psychiatry 158(11): 1843-1849, 2001

Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. ProgressinNeuro-PsychopharmacologyandBiologicalPsychiatry29(1):7, 2005

Characterization of serotonin transporter in goldfish retina by the binding of [3H]paroxetine and the uptake of [3H]serotonin: modulation by light. Journal of Neurochemistry 62(2): 528-535, 1994

Binding of [ 3 H]lysergic Acid Diethylamide to Serotonin 5-Ht 2A Receptors and of [ 3 H]paroxetine to Serotonin Uptake Sites in Platelets from Healthy Children, Adolescents and Adults. Neuropsychobiology 40(4): 183-187, 1999

Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults. Neuropsychobiology 40(4): 183-187, 1999

Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteins. European Journal of Pharmacology 189(2-3): 129-134, 1990

Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse 11(2): 112-123, 1992

In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain. Neurochemical Research 33(11): 2250-2256, 2008

Measuring the serotonin uptake site using tritiated paroxetine a new serotonin uptake inhibitor. Advances in Alcohol & Substance Abuse 7(3-4): 107-112, 1988

Altered serotonin release in the dorsal raphe nucleus at rest and in response to 8 - OH - DPAT but not citalopram following habitual wheel running role of serotonin transporters, 5 - HT1A, and 5 - HT1B receptors. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 711 5, 2003

Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology 30(5): 996-1005, 2005

Citalopram a new potent inhibitor of the serotonin uptake with evident central serotonin mimetic properties. Naunyn-Schmiedeberg's Archives of Pharmacology 313(Suppl.): R30, 1980

Inhibitory and regulatory binding sites on the rat brain serotonin transporter molecular weight of the tritiated paroxetine and tritiated citalopram binding proteins. European Journal of Pharmacology Molecular Pharmacology Section 3(2-3): 129-134, 1990

Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitor. Advances in Alcohol and Substance Abuse 7(3-4): 107-111, 1988

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Journal of Pharmacology and Experimental Therapeutics 242(3): 911-916, 1987